155 related articles for article (PubMed ID: 37195975)
1. The characteristics and survival of second primary lung cancer after Hodgkin's lymphoma: A comparison with first primary lung cancer using the SEER database.
Lin L; Wang D; Chen H
PLoS One; 2023; 18(5):e0285766. PubMed ID: 37195975
[TBL] [Abstract][Full Text] [Related]
2. Survival after second primary lung cancer: a population-based study of 187 Hodgkin lymphoma patients.
Milano MT; Li H; Constine LS; Travis LB
Cancer; 2011 Dec; 117(24):5538-47. PubMed ID: 21692074
[TBL] [Abstract][Full Text] [Related]
3. Variables affecting survival after second primary lung cancer: A population-based study of 187 Hodgkin's lymphoma patients.
Milano MT; Li H; Constine LS; Travis LB
J Thorac Dis; 2012 Feb; 4(1):22-9. PubMed ID: 22295164
[TBL] [Abstract][Full Text] [Related]
4. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
5. Second Primary Non-Small-Cell Lung Cancer After Head and Neck Cancer: A Population-Based Study of Clinical and Pathologic Characteristics and Survival Outcomes in 3597 Patients.
Budnik J; DeNunzio NJ; Singh DP; Milano MT
Clin Lung Cancer; 2020 May; 21(3):195-203. PubMed ID: 30914310
[TBL] [Abstract][Full Text] [Related]
6. Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer.
Huang L; Feng Y; Xie T; Zhu H; Tang L; Shi Y
BMC Cancer; 2023 Apr; 23(1):312. PubMed ID: 37020179
[TBL] [Abstract][Full Text] [Related]
7. Gamma knife radiosurgery for metastatic brain tumors from lung cancer: a comparison between small cell and non-small cell carcinoma.
Serizawa T; Ono J; Iichi T; Matsuda S; Sato M; Odaki M; Hirai S; Osato K; Saeki N; Yamaura A
J Neurosurg; 2002 Dec; 97(5 Suppl):484-8. PubMed ID: 12507082
[TBL] [Abstract][Full Text] [Related]
8. Low diffusion capacity predicts poor prognosis in extensive stage small cell lung cancer: a single-center analysis of 10 years.
Kim JS; Kim EJ; Jang JG; Hong KS; Ahn JH
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7275-7283. PubMed ID: 36912944
[TBL] [Abstract][Full Text] [Related]
9. Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study.
Zhang JT; Li Y; Yan LX; Zhu ZF; Dong XR; Chu Q; Wu L; Zhang HM; Xu CW; Lin G; Yu ZY; Hu J; Zhu B; Wang HJ; Yang F; Song ZB; Han ZB; Li MX; Lin J; Wu YL; Wang JL; Zhong WZ
Lung Cancer; 2020 Jan; 139():118-123. PubMed ID: 31775086
[TBL] [Abstract][Full Text] [Related]
10. KMT2D Mutation Is Associated With Poor Prognosis in Non-Small-Cell Lung Cancer.
Ardeshir-Larijani F; Bhateja P; Lipka MB; Sharma N; Fu P; Dowlati A
Clin Lung Cancer; 2018 Jul; 19(4):e489-e501. PubMed ID: 29627316
[TBL] [Abstract][Full Text] [Related]
11. Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancer.
Rice SJ; Belani CP
PLoS One; 2021; 16(12):e0260988. PubMed ID: 34855926
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of Prognostic Factors and Clinical Characteristics for Patients with Limited Stage Small Cell Lung Cancer with Pleural Effusion].
Xu K; Wang Y; Qi J; Zhao L; Wang P
Zhongguo Fei Ai Za Zhi; 2018 Jan; 21(1):16-23. PubMed ID: 29357968
[TBL] [Abstract][Full Text] [Related]
13. Survival Analysis of Lung Cancer: A 10-Year Real-Life Experience in a Non-University-Based Hospital in Thailand (2012-2021).
Nakwan N; Kumsuk K
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3021-3027. PubMed ID: 37774053
[TBL] [Abstract][Full Text] [Related]
14. Better survival and prognosis in SCLC survivors after combined second primary malignancies: A SEER database-based study.
Wang S; Hu S; Huang S; Su L; Guo Q; Wu B; Ye J; Zhang D; Zhang Y; Zhang W; Wei Y
Medicine (Baltimore); 2023 Feb; 102(6):e32772. PubMed ID: 36820587
[TBL] [Abstract][Full Text] [Related]
15. Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study.
Kinslow CJ; May MS; Saqi A; Shu CA; Chaudhary KR; Wang TJC; Cheng SK
Clin Lung Cancer; 2020 Mar; 21(2):e99-e113. PubMed ID: 31601526
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and prognostic factors of surgically resected combined small cell lung cancer: a retrospective study.
Lei Y; Feng H; Qiang H; Shang Z; Chang Q; Qian J; Zhang Y; Zhong R; Fan X; Chu T
Lung Cancer; 2020 Aug; 146():244-251. PubMed ID: 32592985
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and risk of second primary lung cancer after cervical cancer: A population-based study.
Qian C; Liu H; Feng Y; Meng S; Wang D; Nie M; Xu M
PLoS One; 2020; 15(8):e0231807. PubMed ID: 32756555
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment of metachronous second primary lung cancer after complete resection of non-small cell lung cancer.
Hamaji M; Allen MS; Cassivi SD; Deschamps C; Nichols FC; Wigle DA; Shen KR
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):683-90; discussion 690-1. PubMed ID: 23414986
[TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival among patients with Hodgkin's lymphoma who developed breast cancer: a population-based study.
Milano MT; Li H; Gail MH; Constine LS; Travis LB
J Clin Oncol; 2010 Dec; 28(34):5088-96. PubMed ID: 20975072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
